Neil Cashman
Vermogen: 121 786 $ op 31-08-2026
Vermogen: 121 786 $ op 31-08-2026
Neil R.
Cashman is the founder of Caprion Proteomics, Inc., founded in 2000, and ProMIS Neurosciences, Inc., founded in 2004, where Dr. Cashman holds the title of Director & Chief Scientific Officer.
Dr. Cashman currently serves as Director-ALS Clinic at Vancouver General Hospital since 2005, Director at ALS Society of British Columbia, and Director at Alberta Innovates BioSolutions.
Former positions include Director-Neuromuscular Clinic at Sunnybrook & Womens Foundation, Director-UBC ALS Centre & Professor at the University of British Columbia from 2005 to 2022, and Professor at the University of Toronto from 1998 to 2005.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-05-2026 | 9.318 ( 0,1% ) | 121 786 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Oprichter | 23-01-2004 |
Vancouver General Hospital | Corporate Officer/Principal | 01-07-2005 |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Develops bioindustrial technologies and natural products | Directeur/Bestuurslid | - |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association which provides support to ALS patients | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 02-01-2022 |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2005 |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Oprichter | - |
Sunnybrook & Womens Foundation | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
ProMIS Neurosciences, Inc.
ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sunnybrook & Womens Foundation | |
Vancouver General Hospital | |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Operates as an association which provides support to ALS patients | Commercial Services |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Develops bioindustrial technologies and natural products | Health Technology |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau